February 2019
Deccan Health Care Ltd ("Deccan/Company"), engaged in the business of developing, manufacturing and marketing a broad range of nutraceutical, cosmeceutical, ayurveda and healthcare products, closed the bid subscription of its initial public offering ("IPO") for 42,12,000 equity shares at a price band of INR 95-100 per share amounting to gross proceeds of INR 42.12 Crores, despite volatile markets and lukewarm responses to IPOs recently. The issue has been subscribed to 1.60 times.
Business Standard (read more...)
Equity Bulls (read more...)
Press Trust of India (read more...)
Webindia123 (read more...)
India News (read more...)
January 2019
Born in the quest for ‘vegetarian’ Omega-3, Deccan Healthcare now has 1,500 nutraceuticals
Omega-3 is an important fatty acid with immense health benefits for the body and brain. It is found in abundance in fish oil and many pharmaceutical companies extract the oil to develop it into a pill for daily dosage.
While the health benefits of Omega-3 cannot be disputed, many — especially vegetarians in India — have reservations having it due to the source of the oil.